|
|
|
Volumn 395, Issue , 1996, Pages 81-108
|
|
Validation issues for the use of transgenic mouse mutation assays in risk assessment.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BACTERIAL PROTEIN;
BETA GALACTOSIDASE;
CARCINOGEN;
ESCHERICHIA COLI PROTEIN;
HYBRID PROTEIN;
LACI PROTEIN, BACTERIA;
MUTAGENIC AGENT;
REPRESSOR PROTEIN;
ANIMAL;
CHEMICALLY INDUCED DISORDER;
DNA DAMAGE;
DRUG EFFECT;
EVALUATION;
EXPERIMENTAL NEOPLASM;
FOOD AND DRUG ADMINISTRATION;
GENETICS;
MOUSE;
MUTAGEN TESTING;
PREDICTION AND FORECASTING;
REPRODUCIBILITY;
REVIEW;
RISK ASSESSMENT;
SENSITIVITY AND SPECIFICITY;
STANDARD;
TRANSGENE;
TRANSGENIC MOUSE;
UNITED STATES;
ANIMALS;
BACTERIAL PROTEINS;
BETA-GALACTOSIDASE;
CARCINOGENS;
DNA DAMAGE;
ESCHERICHIA COLI PROTEINS;
EVALUATION STUDIES;
MICE;
MICE, TRANSGENIC;
MUTAGENICITY TESTS;
MUTAGENS;
NEOPLASMS, EXPERIMENTAL;
PREDICTIVE VALUE OF TESTS;
RECOMBINANT FUSION PROTEINS;
REPRESSOR PROTEINS;
REPRODUCIBILITY OF RESULTS;
RISK ASSESSMENT;
SENSITIVITY AND SPECIFICITY;
TRANSGENES;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 0030333624
PISSN: 03617742
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (10)
|
|
References (85)
|
